These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8958811)

  • 21. Percutaneous transluminal coronary angioplasty in the young patients--Siriraj Hospital's experience.
    Singhaviranon L; Mahanonda N; Chotinaiwattarakul C; Chirapastan A; Kwo-Sa-Ard B; Tanapibunpon P; Kanabencha A; Jaidee T; Chaithiraphan S
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S199-205. PubMed ID: 11194015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical analysis of adhesion molecules in directional coronary atherectomy specimens].
    Sakurai S; Inoue A; Ohwa M; Koh CS; Ohkubo K; Hikita H; Kohno H; Yanagisawa N
    J Cardiol; 1995 Sep; 26(3):139-47. PubMed ID: 7473044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased endogenous endothelin-1 in coronary circulation is associated with restenosis after coronary angioplasty.
    Takase H; Sugiyama M; Nakazawa A; Toriyama T; Hayashi K; Goto T; Sato K; Ikeda K; Ueda R; Dohi Y
    Can J Cardiol; 2003 Jul; 19(8):902-6. PubMed ID: 12876610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous transluminal coronary angioplasty for chronic dialysis patients.
    Takeshita S; Isshiki T; Tagawa H; Yamaguchi T
    J Invasive Cardiol; 1993; 5(9):345-50. PubMed ID: 10146597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coronary vasospastic activity at sites of percutaneous transluminal coronary angioplasty: evaluation using intracoronary acetylcholine administration].
    Kirigaya H; Aizawa T; Ogasawara K; Hirosaka A; Sakuma T; Tabuchi T; Mogami H; Ohta A; Kato K
    J Cardiol; 1991; 21(4):869-77. PubMed ID: 1844442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychosomatic determinants of restenosis after percutaneous transluminal coronary angioplasty].
    Titscher G; Huber C; Ambros O; Gruska M; Gaul G
    Z Psychosom Med Psychoanal; 1996; 42(2):154-68. PubMed ID: 8711958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy for the treatment of restenosis after coronary angioplasty].
    Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
    Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty.
    Ueda M; Becker AE; Kasayuki N; Kojima A; Morita Y; Tanaka S
    Am J Pathol; 1996 Sep; 149(3):831-43. PubMed ID: 8780387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing restenosis after coronary angioplasty.
    Popma JJ; Topol EJ
    Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
    Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
    J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence and localization of apoptosis bodies in human arteriosclerosis lesions].
    Bauriedel G; Schluckebier S; Welsch U; Klingel K; Kandolf R; Steinbeck G
    Z Kardiol; 1996 Jul; 85(7):509-18. PubMed ID: 8928549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous transluminal rotational atherectomy for treatment of in-stent restenosis.
    Khanolkar UB
    Indian Heart J; 1996; 48(3):281-2. PubMed ID: 8755017
    [No Abstract]   [Full Text] [Related]  

  • 35. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of patients after coronary angioplasty.
    Popma JJ; Dehmer GJ
    Am Fam Physician; 1990 Jan; 41(1):121-9. PubMed ID: 2403720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coronary restenosis. An unresolved problem of percutaneous transluminal coronary angioplasty].
    Iñíguez Romo A
    Rev Esp Cardiol; 1993; 46 Suppl 3():85-96. PubMed ID: 8303057
    [No Abstract]   [Full Text] [Related]  

  • 38. [Restenosis: physiopathology, treatments and prevention].
    Lafont A; Durand E; Rahal S; de Oliveira M; Guérin Y; Fernandez F; Desnos M; Guérot C
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):349-53. PubMed ID: 8561439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells].
    Voisard R; Dartsch PC; Seitzer U; Grupp C; Hannekum A; Kochs M; Hombach V
    Vasa Suppl; 1991; 33():138-9. PubMed ID: 1788646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Fujikawa H; Shimada K
    Atherosclerosis; 2001 May; 156(1):165-70. PubMed ID: 11369010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.